| 000 | 01500 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250516203602.0 | ||
| 264 | 0 | _c20140721 | |
| 008 | 201407s 0 0 pol d | ||
| 022 | _a1732-2693 | ||
| 024 | 7 |
_a10.5604/17322693.1094714 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKrajewski, Wojciech | |
| 245 | 0 | 0 |
_a[Genetic and immunologic determinants of intravesical BCG therapy in non-muscle-invasive urothelial bladder cancer]. _h[electronic resource] |
| 260 |
_bPostepy higieny i medycyny doswiadczalnej (Online) _cMar 2014 |
||
| 300 |
_a291-300 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 | _aAdministration, Intravesical |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aBCG Vaccine _ximmunology |
| 650 | 0 | 4 |
_aBiomarkers, Tumor _xurine |
| 650 | 0 | 4 |
_aCytokines _xbiosynthesis |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aInterleukin-10 _xurine |
| 650 | 0 | 4 |
_aInterleukin-2 _xurine |
| 650 | 0 | 4 |
_aNeoplasm Recurrence, Local _xprevention & control |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aTumor Necrosis Factor-alpha _xurine |
| 650 | 0 | 4 |
_aUrinary Bladder Neoplasms _xdrug therapy |
| 700 | 1 | _aKołodziej, Anna | |
| 700 | 1 | _aDembowski, Janusz | |
| 700 | 1 | _aZdrojowy, Romuald | |
| 773 | 0 |
_tPostepy higieny i medycyny doswiadczalnej (Online) _gvol. 68 _gp. 291-300 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.5604/17322693.1094714 _zAvailable from publisher's website |
| 999 |
_c23670843 _d23670843 |
||